HDAC6 and amyotrophic lateral sclerosis: Furthermore, HDAC6 deletion or inhibition have been shown to be beneficial for some neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and Charcot-Marie-Tooth disease45–47.